Skip to content

Citrine Capital LLC: NVDA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Citrine Capital LLC on NVDA, newest first. How the timeline and the estimate are built.

Citrine Capital LLC held 186,590 NVDA shares at 2026-06-30 per its 13F-HR filed 2026-07-23.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 186,590 shares
    Change vs previous 13F -37 shares

    13.82% of the 13F portfolio, value $37,334,887.

    13F-HR 0001754960-26-000616 filed by Citrine Capital LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 186,627 shares
    Change vs previous 13F +26 shares

    14.11% of the 13F portfolio, value $32,547,670.

    13F-HR 0001754960-26-000298 filed by Citrine Capital LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 186,601 shares
    Change vs previous 13F +47 shares

    16.16% of the 13F portfolio, value $34,801,002.

    13F-HR 0001754960-26-000092 filed by Citrine Capital LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 186,554 shares
    Change vs previous 13F +8,952 shares

    16.12% of the 13F portfolio, value $34,807,161.

    13F-HR 0001754960-25-000702 filed by Citrine Capital LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 177,602 shares
    Change vs previous 13F 0 shares

    14.9% of the 13F portfolio, value $28,059,269.

    13F-HR 0001754960-25-000429 filed by Citrine Capital LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 177,602 shares
    Change vs previous 13F 0 shares

    12.05% of the 13F portfolio, value $19,248,456.

    13F-HR 0001754960-25-000238 filed by Citrine Capital LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 177,602 shares
    Change vs previous 13F not available

    17.57% of the 13F portfolio, value $23,850,112.

    13F-HR 0001754960-25-000073 filed by Citrine Capital LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).